By Stefan J. Bos, Chief International Correspondent Worthy News
WASHINGTON (Worthy News) – There was hope for at least some cancer patients Thursday after experts announced new treatment may be available from an unexpected source.
Lidocaine, a commonly used local anesthetic that works by blocking signals at the nerve endings in the skin, could play a significant role in successfully treating cancers, concluded researchers at the University of Pennsylvania.
“While we’re not suggesting the lidocaine could cure cancer, we’re galvanized by the possibility that it could get an edge on head and neck cancer treatment. And move the dial forward, in terms of improving treatment options for patients with this challenging form of cancer,” said Ryan Carey, an assistant professor and co-lead author of the study.
Lidocaine activates a particular bitter taste receptor through “two unique mechanisms” that result in cancer cell death, according to researchers from the Perelman School of Medicine at the University of Pennsylvania.
Their findings were published in Cell Reports, Worthy News learned Thursday. The publication paves the way for a clinical trial to test the addition of lidocaine to the standard of care therapy for patients with head and neck cancers, officials said.
The local anesthetic drug has long been suggested to have beneficial effects in cancer patients, but it wasn’t known how or why.
“The team found that lidocaine activates the bitter taste receptor T2R14, which is elevated in various cancer cells. When this receptor is activated, it starts an apoptosis process, causing the cancer cells to die,” researchers said.
“We were surprised to find that lidocaine targets the one receptor that happened to be most highly expressed across cancers,” noted study lead Robert Lee, an assistant professor of Otorhinolaryngology-Head and Neck Surgery at the University of Pennsylvania.
While more research is needed, the discovery has offered more hope for treating several forms of cancer, researchers suggested.
Copyright 1999-2026 Worthy News. This article was originally published on Worthy News and was reproduced with permission.
Latest News from Worthy News
Hungarian Prime Minister Viktor Orbán said over the weekend that Hungary should fear the European Union more than Russia, pledging to dismantle what he called Brussels’ “oppressive machinery” ahead of heated parliamentary elections in April.
U.S. Secretary of State Marco Rubio has pledged to deepen cooperation with a group of four Central and Eastern European nations, including Hungary and Slovakia, despite concerns over their leaders’ perceived authoritarian style and refusal to provide military aid to war-torn Ukraine.
Bulgarian President Iliana Yotova has appointed a senior central bank official as interim prime minister in a bid to steady the European Union nation after years of chronic political instability.
Deutsche Bank, Germany’s largest bank, continued providing banking services to convicted sex offender Jeffrey Epstein years after his 2008 conviction and months before his 2019 arrest, according to U.S. Justice Department documents released Thursday.
Hungary’s main opposition leader, 44-year-old Péter Magyar, said Thursday that he has become the target of what he described as a “Russian-style smear campaign” after he was secretly filmed during a consensual sexual encounter with a former girlfriend in 2024.
The Trump administration has finalized a sweeping reciprocal trade agreement with Taiwan, confirming a 15 percent U.S. tariff rate on Taiwanese imports while securing broad new market access and purchase commitments for American goods.
Democrats are applauding White House border czar Tom Homan’s Thursday announcement that immigration enforcement operation in Minnesota will end next week.